Themis Bioscience is developing urgently needed treatments to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating disease with global outbreak potential. Our innovation in immune modulation technology has created a powerful platform and a growing pipeline addressing a broad range of infectious diseases and cancer. Together with industrial and academic leaders we work to prevent illness across the globe.
Muthgasse 11/2
1190 Vienna
Vienna
Contact:
Telephone: +43 (1) 23671-51
Email: office@themisbio.com
Website